Annual Net Income
$12.67 M
+$211.01 M+106.39%
31 December 2023
Summary:
TG Therapeutics annual net profit is currently $12.67 million, with the most recent change of +$211.01 million (+106.39%) on 31 December 2023. During the last 3 years, it has risen by +$292.05 million (+104.54%). TGTX annual net income is now at all-time high.TGTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$3.88 M
-$3.00 M-43.60%
30 September 2024
Summary:
TG Therapeutics quarterly net profit is currently $3.88 million, with the most recent change of -$3.00 million (-43.60%) on 30 September 2024. Over the past year, it has dropped by -$110.05 million (-96.59%). TGTX quarterly net income is now -96.59% below its all-time high of $113.93 million, reached on 30 September 2023.TGTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$14.36 M
-$110.05 M-115.01%
30 September 2024
Summary:
TG Therapeutics TTM net profit is currently -$14.36 million, with the most recent change of -$110.05 million (-115.01%) on 30 September 2024. Over the past year, it has increased by +$11.54 million (+44.55%). TGTX TTM net income is now -115.01% below its all-time high of $95.69 million, reached on 30 June 2024.TGTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +106.4% | -96.6% | +44.5% |
| 3 y3 years | +104.5% | +104.5% | +95.8% |
| 5 y5 years | +107.3% | +106.3% | +92.3% |
TGTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.6% | -96.6% | +104.2% | -115.0% | +95.9% |
| 5 y | 5 years | at high | +103.6% | -96.6% | +104.2% | -115.0% | +95.9% |
| alltime | all time | at high | +103.6% | -96.6% | +104.2% | -115.0% | +95.9% |
TG Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.88 M(-43.6%) | -$14.36 M(-115.0%) |
| June 2024 | - | $6.88 M(-164.2%) | $95.69 M(+132.3%) |
| Mar 2024 | - | -$10.71 M(-25.7%) | $41.20 M(+225.1%) |
| Dec 2023 | $12.67 M(-106.4%) | -$14.42 M(-112.7%) | $12.67 M(-148.9%) |
| Sept 2023 | - | $113.93 M(-339.3%) | -$25.91 M(-85.3%) |
| June 2023 | - | -$47.61 M(+21.4%) | -$175.65 M(+4.2%) |
| Mar 2023 | - | -$39.23 M(-26.0%) | -$168.55 M(-15.0%) |
| Dec 2022 | -$198.34 M(-43.0%) | -$52.99 M(+48.0%) | -$198.34 M(-16.9%) |
| Sept 2022 | - | -$35.82 M(-11.6%) | -$238.68 M(-17.3%) |
| June 2022 | - | -$40.51 M(-41.3%) | -$288.50 M(-11.6%) |
| Mar 2022 | - | -$69.01 M(-26.1%) | -$326.49 M(-6.2%) |
| Dec 2021 | -$348.10 M(+24.6%) | -$93.34 M(+9.0%) | -$348.10 M(+1.5%) |
| Sept 2021 | - | -$85.64 M(+9.1%) | -$342.98 M(-0.4%) |
| June 2021 | - | -$78.50 M(-13.4%) | -$344.51 M(+8.0%) |
| Mar 2021 | - | -$90.63 M(+2.7%) | -$318.89 M(+14.1%) |
| Dec 2020 | -$279.38 M(+61.6%) | -$88.22 M(+1.2%) | -$279.38 M(+21.1%) |
| Sept 2020 | - | -$87.16 M(+64.8%) | -$230.74 M(+12.3%) |
| June 2020 | - | -$52.88 M(+3.5%) | -$205.50 M(+8.8%) |
| Mar 2020 | - | -$51.12 M(+29.2%) | -$188.83 M(+9.2%) |
| Dec 2019 | -$172.87 M(-0.4%) | -$39.57 M(-36.1%) | -$172.87 M(-7.6%) |
| Sept 2019 | - | -$61.93 M(+71.0%) | -$187.16 M(+17.6%) |
| June 2019 | - | -$36.21 M(+3.0%) | -$159.18 M(-4.7%) |
| Mar 2019 | - | -$35.16 M(-34.7%) | -$167.11 M(-3.7%) |
| Dec 2018 | -$173.48 M(+46.4%) | -$53.86 M(+58.6%) | -$173.48 M(+15.3%) |
| Sept 2018 | - | -$33.95 M(-23.1%) | -$150.48 M(+1.6%) |
| June 2018 | - | -$44.14 M(+6.3%) | -$148.07 M(+11.9%) |
| Mar 2018 | - | -$41.53 M(+34.6%) | -$132.28 M(+11.6%) |
| Dec 2017 | -$118.48 M(+51.4%) | -$30.86 M(-2.1%) | -$118.48 M(+6.5%) |
| Sept 2017 | - | -$31.54 M(+11.2%) | -$111.29 M(+6.4%) |
| June 2017 | - | -$28.35 M(+2.3%) | -$104.59 M(+13.5%) |
| Mar 2017 | - | -$27.73 M(+17.1%) | -$92.13 M(+17.7%) |
| Dec 2016 | -$78.25 M(+24.3%) | -$23.67 M(-4.7%) | -$78.25 M(+8.4%) |
| Sept 2016 | - | -$24.83 M(+56.2%) | -$72.19 M(+18.3%) |
| June 2016 | - | -$15.90 M(+14.8%) | -$61.02 M(-1.9%) |
| Mar 2016 | - | -$13.85 M(-21.4%) | -$62.22 M(-1.2%) |
| Dec 2015 | -$62.95 M(+12.8%) | -$17.61 M(+29.0%) | -$62.95 M(-1.8%) |
| Sept 2015 | - | -$13.66 M(-20.2%) | -$64.13 M(-5.6%) |
| June 2015 | - | -$17.10 M(+17.3%) | -$67.93 M(+8.1%) |
| Mar 2015 | - | -$14.58 M(-22.4%) | -$62.81 M(+12.6%) |
| Dec 2014 | -$55.78 M(+172.4%) | -$18.80 M(+7.7%) | -$55.78 M(+30.8%) |
| Sept 2014 | - | -$17.45 M(+45.6%) | -$42.65 M(+43.3%) |
| June 2014 | - | -$11.99 M(+58.8%) | -$29.75 M(+22.2%) |
| Mar 2014 | - | -$7.55 M(+33.3%) | -$24.35 M(+18.9%) |
| Dec 2013 | -$20.48 M(+13.3%) | -$5.66 M(+24.3%) | -$20.48 M(+12.1%) |
| Sept 2013 | - | -$4.56 M(-30.8%) | -$18.27 M(+12.9%) |
| June 2013 | - | -$6.58 M(+79.2%) | -$16.18 M(+40.8%) |
| Mar 2013 | - | -$3.67 M(+6.2%) | -$11.49 M(-36.4%) |
| Dec 2012 | -$18.07 M(+2018.5%) | -$3.46 M(+40.5%) | -$18.07 M(+19.2%) |
| Sept 2012 | - | -$2.46 M(+30.0%) | -$15.16 M(+19.1%) |
| June 2012 | - | -$1.89 M(-81.5%) | -$12.72 M(+14.5%) |
| Mar 2012 | - | -$10.26 M(+1790.9%) | -$11.11 M(-7.1%) |
| Dec 2011 | -$853.10 K(-236.8%) | -$542.40 K(+1796.5%) | -$11.96 M(+8.2%) |
| Sept 2011 | - | -$28.60 K(-89.9%) | -$11.05 M(+0.6%) |
| June 2011 | - | -$282.10 K(-97.5%) | -$10.98 M(+24.1%) |
| Mar 2011 | - | -$11.11 M(-3141.9%) | -$8.85 M(-1519.8%) |
| Dec 2010 | $623.60 K | $365.20 K(+786.4%) | $623.50 K(+1661.3%) |
| Sept 2010 | - | $41.20 K(-97.8%) | $35.40 K(-108.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $1.85 M(-213.3%) | -$421.90 K(-88.5%) |
| Mar 2010 | - | -$1.63 M(+632.7%) | -$3.66 M(+31.2%) |
| Dec 2009 | -$2.79 M(-34.6%) | -$222.90 K(-46.4%) | -$2.79 M(+14.3%) |
| Sept 2009 | - | -$416.10 K(-70.1%) | -$2.44 M(-28.6%) |
| June 2009 | - | -$1.39 M(+82.8%) | -$3.42 M(-0.9%) |
| Mar 2009 | - | -$761.80 K(-699.8%) | -$3.45 M(-18.8%) |
| Dec 2008 | -$4.27 M(-64.5%) | $127.00 K(-109.1%) | -$4.25 M(-32.3%) |
| Sept 2008 | - | -$1.39 M(-2.0%) | -$6.28 M(-16.9%) |
| June 2008 | - | -$1.42 M(-8.8%) | -$7.56 M(-31.5%) |
| Mar 2008 | - | -$1.56 M(-18.1%) | -$11.03 M(-8.4%) |
| Dec 2007 | -$12.03 M(+24.1%) | -$1.90 M(-28.7%) | -$12.03 M(-9.2%) |
| Sept 2007 | - | -$2.67 M(-45.5%) | -$13.26 M(+6.2%) |
| June 2007 | - | -$4.89 M(+90.9%) | -$12.48 M(+26.6%) |
| Mar 2007 | - | -$2.56 M(-18.0%) | -$9.86 M(+1.7%) |
| Dec 2006 | -$9.70 M(-49.3%) | -$3.13 M(+64.9%) | -$9.70 M(+6.4%) |
| Sept 2006 | - | -$1.90 M(-16.5%) | -$9.11 M(+0.9%) |
| June 2006 | - | -$2.27 M(-5.3%) | -$9.02 M(-55.1%) |
| Mar 2006 | - | -$2.40 M(-5.6%) | -$20.11 M(+5.1%) |
| Dec 2005 | -$19.14 M(+224.6%) | -$2.54 M(+40.2%) | -$19.14 M(+4.3%) |
| Sept 2005 | - | -$1.81 M(-86.4%) | -$18.34 M(-2.0%) |
| June 2005 | - | -$13.36 M(+836.9%) | -$18.73 M(+200.7%) |
| Mar 2005 | - | -$1.43 M(-18.3%) | -$6.23 M(+5.6%) |
| Dec 2004 | -$5.90 M(-1.1%) | -$1.75 M(-20.5%) | -$5.90 M(+4.2%) |
| Sept 2004 | - | -$2.19 M(+154.7%) | -$5.66 M(-15.8%) |
| June 2004 | - | -$861.60 K(-21.3%) | -$6.72 M(+1.3%) |
| Mar 2004 | - | -$1.10 M(-27.4%) | -$6.63 M(+11.3%) |
| Dec 2003 | -$5.96 M(+474.7%) | -$1.51 M(-53.6%) | -$5.96 M(+38.2%) |
| Sept 2003 | - | -$3.25 M(+319.0%) | -$4.31 M(+162.0%) |
| June 2003 | - | -$776.30 K(+84.0%) | -$1.65 M(+46.7%) |
| Mar 2003 | - | -$421.90 K(-403.7%) | -$1.12 M(-15.3%) |
| Dec 2002 | -$1.04 M(-40.2%) | $138.90 K(-123.7%) | -$1.32 M(-34.7%) |
| Sept 2002 | - | -$586.40 K(+132.1%) | -$2.03 M(-6.9%) |
| June 2002 | - | -$252.60 K(-59.5%) | -$2.18 M(-46.2%) |
| Mar 2002 | - | -$624.10 K(+10.4%) | -$4.05 M(+133.2%) |
| Dec 2001 | -$1.73 M(-70.1%) | -$565.20 K(-23.2%) | -$1.74 M(+13.1%) |
| Sept 2001 | - | -$735.60 K(-65.3%) | -$1.53 M(-13.4%) |
| June 2001 | - | -$2.12 M(-225.7%) | -$1.77 M(-35.3%) |
| Mar 2001 | - | $1.69 M(-562.8%) | -$2.74 M(-52.8%) |
| Dec 2000 | -$5.80 M(+141.8%) | -$364.50 K(-62.5%) | -$5.80 M(-3.9%) |
| Sept 2000 | - | -$972.40 K(-68.5%) | -$6.04 M(+12.5%) |
| June 2000 | - | -$3.09 M(+124.0%) | -$5.37 M(+86.4%) |
| Mar 2000 | - | -$1.38 M(+129.7%) | -$2.88 M(+19.9%) |
| Dec 1999 | -$2.40 M(-14.3%) | -$600.00 K(+100.0%) | -$2.40 M(-22.6%) |
| Sept 1999 | - | -$300.00 K(-50.0%) | -$3.10 M(-22.5%) |
| June 1999 | - | -$600.00 K(-33.3%) | -$4.00 M(+66.7%) |
| Mar 1999 | - | -$900.00 K(-30.8%) | -$2.40 M(-14.3%) |
| Dec 1998 | -$2.80 M(-46.2%) | -$1.30 M(+8.3%) | -$2.80 M(-6.7%) |
| Sept 1998 | - | -$1.20 M(-220.0%) | -$3.00 M(+7.1%) |
| June 1998 | - | $1.00 M(-176.9%) | -$2.80 M(-50.0%) |
| Mar 1998 | - | -$1.30 M(-13.3%) | -$5.60 M(+7.7%) |
| Dec 1997 | -$5.20 M(+44.4%) | -$1.50 M(+50.0%) | -$5.20 M(+10.6%) |
| Sept 1997 | - | -$1.00 M(-44.4%) | -$4.70 M(-2.1%) |
| June 1997 | - | -$1.80 M(+100.0%) | -$4.80 M(+26.3%) |
| Mar 1997 | - | -$900.00 K(-10.0%) | -$3.80 M(+2.7%) |
| Dec 1996 | -$3.60 M | -$1.00 M(-9.1%) | -$3.70 M(+37.0%) |
| Sept 1996 | - | -$1.10 M(+37.5%) | -$2.70 M(+68.8%) |
| June 1996 | - | -$800.00 K(0.0%) | -$1.60 M(+100.0%) |
| Mar 1996 | - | -$800.00 K | -$800.00 K |
FAQ
- What is TG Therapeutics annual net profit?
- What is the all time high annual net income for TG Therapeutics?
- What is TG Therapeutics annual net income year-on-year change?
- What is TG Therapeutics quarterly net profit?
- What is the all time high quarterly net income for TG Therapeutics?
- What is TG Therapeutics quarterly net income year-on-year change?
- What is TG Therapeutics TTM net profit?
- What is the all time high TTM net income for TG Therapeutics?
- What is TG Therapeutics TTM net income year-on-year change?
What is TG Therapeutics annual net profit?
The current annual net income of TGTX is $12.67 M
What is the all time high annual net income for TG Therapeutics?
TG Therapeutics all-time high annual net profit is $12.67 M
What is TG Therapeutics annual net income year-on-year change?
Over the past year, TGTX annual net profit has changed by +$211.01 M (+106.39%)
What is TG Therapeutics quarterly net profit?
The current quarterly net income of TGTX is $3.88 M
What is the all time high quarterly net income for TG Therapeutics?
TG Therapeutics all-time high quarterly net profit is $113.93 M
What is TG Therapeutics quarterly net income year-on-year change?
Over the past year, TGTX quarterly net profit has changed by -$110.05 M (-96.59%)
What is TG Therapeutics TTM net profit?
The current TTM net income of TGTX is -$14.36 M
What is the all time high TTM net income for TG Therapeutics?
TG Therapeutics all-time high TTM net profit is $95.69 M
What is TG Therapeutics TTM net income year-on-year change?
Over the past year, TGTX TTM net profit has changed by +$11.54 M (+44.55%)